Third Rock Ventures Iii, L.P. Jounce Therapeutics, Inc. (JNCE) insider trading activity

Third Rock Ventures Iii, L.P. is > 10% Shareholder of Jounce Therapeutics, Inc.. Currently has a direct ownership of 1.15 Million shares of JNCE, which is worth approximately $0. The most recent transaction as insider was on Nov 12, 2021, when has been sold 1,900,000 shares (Common Stock) at a price of $8.38 per share, resulting in proceeds of $15,922,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.15M

0% 3M change

0% 12M change

Total Value Held $0

Third Rock Ventures III, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Nov 12 2021	SELL Open market or private sale	$15,922,000 $8.38 p/Share	1,900,000 Reduced 62.32%	1,148,780 Common Stock

Also insider at

MYOK

MyoKardia Inc

> 10% Shareholder

VYGR

Voyager Therapeutics, Inc. Healthcare

> 10% Shareholder

NTGN

Neon Therapeutics, Inc.

> 10% Shareholder

FULC

Fulcrum Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

PLRX

PLIANT THERAPEUTICS, INC. Healthcare

> 10% Shareholder

RLAY

Relay Therapeutics, Inc. Healthcare

> 10% Shareholder

NRIX

Nurix Therapeutics, Inc. Healthcare

> 10% Shareholder

TRV